Koopman Daniëlle, van Dalen Jorn A, Stigt Jos A, Slump Cornelis H, Knollema Siert, Jager Pieter L
Department of Nuclear Medicine, Isala, Dokter van Heesweg 2, 8025 AB, Zwolle, The Netherlands.
MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands.
Ann Nucl Med. 2016 Feb;30(2):145-52. doi: 10.1007/s12149-015-1041-z. Epub 2015 Dec 7.
Modern PET/CT scanners have significantly improved detectors and fast time-of-flight (TOF) performance and this may improve clinical performance. The aim of this study was to analyze the impact of a current generation TOF PET/CT scanner on standardized uptake values (SUV), lesion-background contrast and characterization of the adrenal glands in patients with suspected lung cancer, in comparison with literature data and commonly used SUV cut-off levels.
We included 149 adrenal glands from 88 patients with suspected lung cancer, who underwent (18)F-FDG PET/CT. We measured the SUVmax in the adrenal gland and compared this with liver SUVmean to calculate the adrenal-to-liver ratio (AL ratio). Results were compared with literature derived with older scanners, with SUVmax values of 1.0 and 1.8 for normal glands [1, 2]. Final diagnosis was based on histological proof or follow-up imaging. We proposed cut-off values for optimal separation of benign from malignant glands.
In 127 benign and 22 malignant adrenal glands, SUVmax values were 2.3 ± 0.7 (mean ± SD) and 7.8 ± 3.2 respectively (p < 0.01). Corresponding AL ratios were 1.0 ± 0.3 and 3.5 ± 1.4 respectively (p < 0.01). With a SUVmax cut-off value of 3.7, 96% sensitivity and 96% specificity was reached. An AL ratio cut-off value of 1.8 resulted in 91% sensitivity and 97% specificity. The ability of both SUVmax and AL ratio to separate benign from malignant glands was similar (AUC 0.989 vs. 0.993, p = 0.22).
Compared with literature based on the previous generation of PET scanners, current generation TOF (18)F-FDG PET/CT imaging provides higher SUVs for benign adrenal glands, while it maintains a highly accurate distinction between benign and malignant glands. Clinical implementation of current generation TOF PET/CT requires not only the use of higher cut-off levels but also visual adaptation by PET readers.
现代PET/CT扫描仪显著改进了探测器及快速飞行时间(TOF)性能,这可能会改善临床性能。本研究的目的是分析与文献数据及常用SUV截止水平相比,新一代TOF PET/CT扫描仪对疑似肺癌患者肾上腺标准化摄取值(SUV)、病灶与背景对比度及肾上腺特征的影响。
我们纳入了88例疑似肺癌患者的149个肾上腺,这些患者均接受了(18)F-FDG PET/CT检查。我们测量了肾上腺的SUVmax,并将其与肝脏SUVmean进行比较以计算肾上腺与肝脏比值(AL比值)。将结果与使用较旧扫描仪得出的文献结果进行比较,正常肾上腺的SUVmax值为1.0和1.8 [1, 2]。最终诊断基于组织学证据或随访影像。我们提出了用于良性与恶性肾上腺最佳区分的截止值。
在127个良性肾上腺和22个恶性肾上腺中,SUVmax值分别为2.3±0.7(均值±标准差)和7.8±3.2(p<0.01)。相应的AL比值分别为1.0±0.3和3.5±1.4(p<0.01)。当SUVmax截止值为3.7时,灵敏度达到96%,特异性达到96%。AL比值截止值为1.8时,灵敏度为91%,特异性为97%。SUVmax和AL比值区分良性与恶性肾上腺的能力相似(曲线下面积分别为0.989和0.993,p = 0.22)。
与基于上一代PET扫描仪的文献相比,新一代TOF(18)F-FDG PET/CT成像为良性肾上腺提供了更高的SUV值,同时保持了对良性和恶性肾上腺的高度准确区分。新一代TOF PET/CT的临床应用不仅需要使用更高的截止水平,还需要PET阅片者进行视觉适应。